PHYSIOLOGICAL AND PATHOLOGICAL IMPACT OF HEPATITIS B AND C, PUBLIC HEALTH STRATEGIES FOR PREVENTION AND CONTROL

Main Article Content

Muhammad Israr Ul Haq
Saeed Anwar
Ghazala Yasmeen Iqbal
Hafiz Umer Farooq
Sonia Nisar
Hatf Rana

Keywords

Hepatitis B, Hepatitis C, Liver Function, Cirrhosis, Public Health, Pakistan

Abstract

Objectives: The goal of this study is to analyze the physiological and pathological impacts of hepatitis B and C on liver and to measure the effectiveness of the health-related prevention and control programs in Pakistan.


Materials and Methods: This was a cross-sectional and prospective investigation of 200 patients with chronic hepatitis B or C in Karachi, Pakistan, who were evaluated with liver function tests (ALT, AST), abdominal ultrasonography, and serological markers. Demographic factors, health behavior, and medical history data were also captured.


Results: Both hepatitis B and C patients were shown to have increased ALT and AST, with hepatitis C presenting higher results for both tests. In contrast, 40% of hepatitis C patients were shown to have cirrhosis via ultrasound examination compared to 20% of hepatitis B patients. A large proportion of the participants came from low household incomes, and many did not know their infection status.


Conclusion: Hepatitis B and C are medically categorized as Liver disorders with Hepatitis C being more dangerous to the liver than Hepatitis B. As a result, early diagnosis and intervention were critical for improving health status.

Abstract 88 | Pdf Downloads 44

References

1- Iannacone, M. and Guidotti, L.G., 2022. Immunobiology and pathogenesis of hepatitis B virus infection. Nature Reviews Immunology, 22(1), pp.19-32
2- World Health Organization, 2020. Training modules on Hepatitis B and C screening, diagnosis and treatment.
3- Lu, J., Xing, H., Wang, C., Tang, M., Wu, C., Ye, F., Yin, L., Yang, Y., Tan, W. and Shen, L., 2023. Mpox (formerly monkeypox): pathogenesis, prevention, and treatment. Signal Transduction and Targeted Therapy, 8(1), p.458.
4- Zhao, F., Xie, X., Tan, X., Yu, H., Tian, M., Lv, H., Qin, C., Qi, J. and Zhu, Q., 2021. The functions of hepatitis B virus encoding proteins: viral persistence and liver pathogenesis. Frontiers in immunology, 12, p.691766.
5- You, H., Wang, X., Ma, L., Zhang, F., Zhang, H., Wang, Y., Pan, X., Zheng, K., Kong, F. and Tang, R., 2023. Insights into the impact of hepatitis B virus on hepatic stellate cell activation. Cell Communication and Signaling, 21(1), p.70.
6- El Sayed, S.M., 2023. Al-hijamah (prophetic wet cupping therapy) is a novel adjuvant treatment for viral hepatitis that excretes viral particles and excess ferritin percutaneously, synergizes pharmacotherapy, enhances antiviral immunity and helps better HCC prevention and treatment: a novel evidence-based combination with prophetic medicine remedies. Journal of Hepatocellular Carcinoma, pp.1527-1546.
7- Assefa, M. and Biset, S., 2024. Prevalence of hepatitis B and C virus infections among visceral leishmaniasis patients: A systematic review and meta-analysis. Frontiers in Microbiology, 15, p.1415330.
8- Block, P.D., Shinn, B., Kim, J.H. and Hann, H.W., 2021. Hepatitis B-related hepatocellular carcinoma and stress: untangling the host immune response from clinical outcomes. Hepatic Oncology, 8(1), p.HEP35.
9- Alaridah, N., Joudeh, R.M., Al-Abdallat, H., Jarrar, R.A.F., Ismail, L., Jum’ah, M., Alnajjar, Z., Alzyoud, E., Battah, Z., Battah, A. and Alshami, M., 2023. Knowledge, attitude, and practices toward Hepatitis B infection among healthcare students—a nationwide cross-sectional study in Jordan. International Journal of Environmental Research and Public Health, 20(5), p.4348.
10- Bryant, J., Smith, A.K., Persson, A., Valentine, K., Drysdale, K., Wallace, J., Hamilton, M. and Newman, C.E., 2023. Logics of control and self-management in narratives of people living with HIV, hepatitis C and hepatitis B. Culture, Health & Sexuality, 25(9), pp.1214-1229.
11- Vimali, J., Yong, Y.K., Murugesan, A., Vishnupriya, K., Ashwin, R., Daniel, E.A., Balakrishnan, P., Raju, S., Rosmawati, M., Velu, V. and Larsson, M., 2022. Plasma interleukin-7 correlation with human immunodeficiency virus RNA and CD4+ T cell counts, and interleukin-5 with circulating hepatitis B virus DNA may have implications in viral control. Frontiers in medicine, 9, p.1019230.
12- Xia, Y., Cheng, X., Nilsson, T., Zhang, M., Zhao, G., Inuzuka, T., Teng, Y., Li, Y., Anderson, D.E., Holdorf, M. and Liang, T.J., 2023. Nucleolin binds to and regulates transcription of hepatitis B virus covalently closed circular DNA minichromosome. Proceedings of the National Academy of Sciences, 120(49), p.e2306390120.
13- Zhang, X., Wang, X., Wu, M., Ghildyal, R. and Yuan, Z., 2021. Animal models for the study of hepatitis B virus pathobiology and immunity: past, present, and future. Frontiers in microbiology, 12, p.715450.
14- Zai, W., Hu, K., Ye, J., Ding, J., Huang, C., Li, Y., Fang, Z., Wu, M., Wang, C., Chen, J. and Yuan, Z., 2022. Long-term hepatitis B virus infection induces cytopathic effects in primary human hepatocytes, and can be partially reversed by antiviral therapy. Microbiology Spectrum, 10(1), pp.e01328-21.
15- Zorob, T., Farooqi, M.A., Ahsan, A., Zaki, A., Rathore, M.A. and Farooqi, H.M.U., 2023. Prevalence and Trends in Hepatitis B & C Virus among Blood Donors in Pakistan: A Regional Transfusion Center Study. Livers, 3(2), pp.271-281.